These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 17601629)

  • 61. Separation of drug-loaded nanoparticles from free drug by gel filtration.
    Beck P; Scherer D; Kreuter J
    J Microencapsul; 1990; 7(4):491-6. PubMed ID: 2266474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide.
    Galia A; Scialdone O; Filardo G; Spanò T
    Int J Pharm; 2009 Jul; 377(1-2):60-9. PubMed ID: 19439168
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
    Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
    Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Modulation of in vivo fate of drugs: fundamental biopharmaceutical and pharmacokinetic aspects].
    Devissaguet JP
    Ann Pharm Fr; 2001 Jul; 59(4):219-26. PubMed ID: 11468575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Towards sustainability: new approaches to nano-drug preparation.
    Cheow WS; Xu R; Hadinoto K
    Curr Pharm Des; 2013; 19(35):6229-45. PubMed ID: 23469999
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Early development drug formulation on a chip: fabrication of nanoparticles using a microfluidic spray dryer.
    Thiele J; Windbergs M; Abate AR; Trebbin M; Shum HC; Förster S; Weitz DA
    Lab Chip; 2011 Jul; 11(14):2362-8. PubMed ID: 21617823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. How to measure release from nanosized carriers?
    Nothnagel L; Wacker MG
    Eur J Pharm Sci; 2018 Jul; 120():199-211. PubMed ID: 29751101
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.
    Crisp MT; Tucker CJ; Rogers TL; Williams RO; Johnston KP
    J Control Release; 2007 Feb; 117(3):351-9. PubMed ID: 17239469
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmaceutical product development technologies based on the biopharmaceutical classification system.
    Jain D; Pathak D; Pathak K
    Pharmazie; 2009 Aug; 64(8):483-90. PubMed ID: 19746834
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
    Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
    Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design and production of nanoparticles formulated from nano-emulsion templates-a review.
    Anton N; Benoit JP; Saulnier P
    J Control Release; 2008 Jun; 128(3):185-99. PubMed ID: 18374443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.